Share
12,186 Posts.
lightbulb Created with Sketch. 1082
clock Created with Sketch. 01/02/21
13:19
Share
Originally posted by bedger:
↑
Oversold. Shorters called it to their credit from $5+, but its too low given its potential prospects. Whispers of Novartis deal still happening or CHF partnership perhaps? Continued upbeat sentiment on a decent Appendix 4C. I'd bought in more in low $2 on partnership prospects. CHF just too sweet for my liking and as posted the MACE end-points were pre-specified (welcome any insightful disagreement from experts) in the CHF trials and the data-mining accusations without merit in my opinion.
Expand
Hi Bedger,
(20min delay)